Calendar Companies Compare Analytics Learn Watchlist

Search CatalystAlert

Search for companies, drugs, and catalysts

Loading market movers...

Free biotech catalyst calendar tracking FDA decisions, clinical trial results, and PDUFA dates for biotech stocks.

Quick Links

Catalyst Calendar
Search Companies
Biotech Glossary
Therapeutic Areas

Legal

About
Privacy
Terms

Data Sources

ClinicalTrials.gov
SEC EDGAR
FDA

© 2025 CatalystAlert. All rights reserved.

Not financial advice. Data may be delayed or incomplete.

Lumateperone - Phase 3 | ITCI Pipeline | CatalystAlert

Lumateperone

Phase 3

Intra-Cellular Therapies, Inc. (ITCI)

50%

Phase 3

Development Phase

3

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts

Sep 2026~

ITCI⭐Phase 3Phase 3

Lumateperone Phase 3 Results Expected

Lumateperone • Major Depressive Disorder

May 2026~

ITCI⭐Phase 3Phase 3

Lumateperone Phase 3 Results Expected

Lumateperone • Major Depressive Disorder

Mar 2026~

ITCI⭐Phase 3Phase 3

Lumateperone Phase 3 Results Expected

Lumateperone • Major Depressive Disorder

Drug Information

Target Indication

Major Depressive Disorder

Clinical Trial

Last updated: 12/4/2025

Developer

ITCI

Intra-Cellular Therapies, Inc.

Biotechnology•North America•NASDAQ